ID   PIGV_HUMAN              Reviewed;         493 AA.
AC   Q9NUD9; D3DPL2; Q5JYG7; Q5JYG8; Q5JYG9; Q9NX26;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 120.
DE   RecName: Full=GPI mannosyltransferase 2;
DE            EC=2.4.1.-;
DE   AltName: Full=GPI mannosyltransferase II;
DE            Short=GPI-MT-II;
DE   AltName: Full=Phosphatidylinositol-glycan biosynthesis class V protein;
DE            Short=PIG-V;
GN   Name=PIGV;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   DESCRIPTION OF HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME.
RX   PubMed=5465362; DOI=10.1016/S0022-3476(70)80047-6;
RA   Mabry C.C., Bautista A., Kirk R.F., Dubilier L.D., Braunstein H.,
RA   Koepke J.A.;
RT   "Familial hyperphosphatase with mental retardation, seizures, and
RT   neurologic deficits.";
RL   J. Pediatr. 77:74-85(1970).
RN   [6]
RP   FUNCTION.
RX   PubMed=15720390; DOI=10.1111/j.1742-4658.2005.04551.x;
RA   Fabre A.-L., Orlean P., Taron C.H.;
RT   "Saccharomyces cerevisiae Ybr004c and its human homologue are required
RT   for addition of the second mannose during glycosylphosphatidylinositol
RT   precursor assembly.";
RL   FEBS J. 272:1160-1168(2005).
RN   [7]
RP   FUNCTION, PATHWAY, SUBCELLULAR LOCATION, TOPOLOGY, LACK OF
RP   GLYCOSYLATION, AND MUTAGENESIS OF TRP-66; ASP-67; 293-PRO-PRO-294;
RP   GLN-308 AND TRP-312.
RX   PubMed=15623507; DOI=10.1074/jbc.M413867200;
RA   Kang J.Y., Hong Y., Ashida H., Shishioh N., Murakami Y., Morita Y.S.,
RA   Maeda Y., Kinoshita T.;
RT   "PIG-V involved in transferring the second mannose in
RT   glycosylphosphatidylinositol.";
RL   J. Biol. Chem. 280:9489-9497(2005).
RN   [8]
RP   DESCRIPTION OF HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME.
RX   PubMed=20578257; DOI=10.1002/ajmg.a.33438;
RA   Thompson M.D., Nezarati M.M., Gillessen-Kaesbach G., Meinecke P.,
RA   Mendoza R., Mornet E., Brun-Heath I., Squarcioni C.P.,
RA   Legeai-Mallet L., Munnich A., Cole D.E.;
RT   "Hyperphosphatasia with seizures, neurologic deficit, and
RT   characteristic facial features: Five new patients with Mabry
RT   syndrome.";
RL   Am. J. Med. Genet. A 152:1661-1669(2010).
RN   [9]
RP   VARIANTS HPMRS1 LYS-256; VAL-341; GLU-341 AND PRO-385.
RX   PubMed=20802478; DOI=10.1038/ng.653;
RA   Krawitz P.M., Schweiger M.R., Rodelsperger C., Marcelis C., Kolsch U.,
RA   Meisel C., Stephani F., Kinoshita T., Murakami Y., Bauer S., Isau M.,
RA   Fischer A., Dahl A., Kerick M., Hecht J., Kohler S., Jager M.,
RA   Grunhagen J., de Condor B.J., Doelken S., Brunner H.G., Meinecke P.,
RA   Passarge E., Thompson M.D., Cole D.E., Horn D., Roscioli T.,
RA   Mundlos S., Robinson P.N.;
RT   "Identity-by-descent filtering of exome sequence data identifies PIGV
RT   mutations in hyperphosphatasia mental retardation syndrome.";
RL   Nat. Genet. 42:827-829(2010).
CC   -!- FUNCTION: Alpha-1,6-mannosyltransferase involved in
CC       glycosylphosphatidylinositol-anchor biosynthesis. Transfers the
CC       second mannose to the glycosylphosphatidylinositol during GPI
CC       precursor assembly. {ECO:0000269|PubMed:15623507,
CC       ECO:0000269|PubMed:15720390}.
CC   -!- PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-
CC       anchor biosynthesis. {ECO:0000269|PubMed:15623507}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15623507}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15623507}.
CC   -!- PTM: Not N-glycosylated. {ECO:0000269|PubMed:15623507}.
CC   -!- DISEASE: Hyperphosphatasia with mental retardation syndrome 1
CC       (HPMRS1) [MIM:239300]: A severe syndrome characterized by elevated
CC       serum alkaline phosphatase, severe mental retardation, seizures,
CC       hypotonia, facial dysmorphism, and hypoplastic terminal phalanges.
CC       {ECO:0000269|PubMed:20802478}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PIGV family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI21625.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI21626.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI21627.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK000484; BAA91196.1; -; mRNA.
DR   EMBL; AL034380; CAB92120.1; -; Genomic_DNA.
DR   EMBL; AL034380; CAI21625.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL034380; CAI21626.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL034380; CAI21627.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471059; EAX07790.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07791.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07792.1; -; Genomic_DNA.
DR   EMBL; BC013568; AAH13568.1; -; mRNA.
DR   CCDS; CCDS287.1; -.
DR   RefSeq; NP_001189483.1; NM_001202554.1.
DR   RefSeq; NP_060307.2; NM_017837.3.
DR   UniGene; Hs.259605; -.
DR   UniGene; Hs.732254; -.
DR   ProteinModelPortal; Q9NUD9; -.
DR   BioGrid; 120782; 1.
DR   STRING; 9606.ENSP00000078527; -.
DR   CAZy; GT76; Glycosyltransferase Family 76.
DR   iPTMnet; Q9NUD9; -.
DR   PhosphoSitePlus; Q9NUD9; -.
DR   BioMuta; PIGV; -.
DR   DMDM; 74752975; -.
DR   MaxQB; Q9NUD9; -.
DR   PaxDb; Q9NUD9; -.
DR   PeptideAtlas; Q9NUD9; -.
DR   PRIDE; Q9NUD9; -.
DR   DNASU; 55650; -.
DR   Ensembl; ENST00000078527; ENSP00000078527; ENSG00000060642.
DR   Ensembl; ENST00000374145; ENSP00000363260; ENSG00000060642.
DR   GeneID; 55650; -.
DR   KEGG; hsa:55650; -.
DR   UCSC; uc001bmz.4; human.
DR   CTD; 55650; -.
DR   DisGeNET; 55650; -.
DR   GeneCards; PIGV; -.
DR   H-InvDB; HIX0159960; -.
DR   HGNC; HGNC:26031; PIGV.
DR   HPA; HPA054181; -.
DR   MalaCards; PIGV; -.
DR   MIM; 239300; phenotype.
DR   MIM; 610274; gene.
DR   neXtProt; NX_Q9NUD9; -.
DR   OpenTargets; ENSG00000060642; -.
DR   Orphanet; 247262; Hyperphosphatasia-intellectual disability syndrome.
DR   PharmGKB; PA134952230; -.
DR   eggNOG; KOG2647; Eukaryota.
DR   eggNOG; COG5542; LUCA.
DR   GeneTree; ENSGT00390000013174; -.
DR   HOGENOM; HOG000232162; -.
DR   HOVERGEN; HBG080592; -.
DR   InParanoid; Q9NUD9; -.
DR   KO; K07542; -.
DR   OMA; VGFLKYY; -.
DR   OrthoDB; EOG091G05ZJ; -.
DR   PhylomeDB; Q9NUD9; -.
DR   TreeFam; TF314515; -.
DR   Reactome; R-HSA-162710; Synthesis of glycosylphosphatidylinositol (GPI).
DR   UniPathway; UPA00196; -.
DR   GeneWiki; PIGV; -.
DR   GenomeRNAi; 55650; -.
DR   PRO; PR:Q9NUD9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000060642; -.
DR   CleanEx; HS_PIGV; -.
DR   ExpressionAtlas; Q9NUD9; baseline and differential.
DR   Genevisible; Q9NUD9; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0031501; C:mannosyltransferase complex; IBA:GO_Central.
DR   GO; GO:0004584; F:dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity; IEA:InterPro.
DR   GO; GO:0004376; F:glycolipid mannosyltransferase activity; TAS:Reactome.
DR   GO; GO:0000030; F:mannosyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0006506; P:GPI anchor biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome.
DR   InterPro; IPR007315; PIG-V/Gpi18.
DR   PANTHER; PTHR12468; PTHR12468; 1.
DR   Pfam; PF04188; Mannosyl_trans2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Endoplasmic reticulum;
KW   Glycosyltransferase; GPI-anchor biosynthesis; Membrane;
KW   Mental retardation; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    493       GPI mannosyltransferase 2.
FT                                /FTId=PRO_0000246234.
FT   TOPO_DOM      1     13       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     14     34       Helical. {ECO:0000255}.
FT   TOPO_DOM     35     77       Lumenal. {ECO:0000255}.
FT   TRANSMEM     78     98       Helical. {ECO:0000255}.
FT   TOPO_DOM     99    113       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    114    134       Helical. {ECO:0000255}.
FT   TOPO_DOM    135    136       Lumenal. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TOPO_DOM    158    161       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    162    182       Helical. {ECO:0000255}.
FT   TOPO_DOM    183    192       Lumenal. {ECO:0000255}.
FT   TRANSMEM    193    213       Helical. {ECO:0000255}.
FT   TOPO_DOM    214    234       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical. {ECO:0000255}.
FT   TOPO_DOM    256    327       Lumenal. {ECO:0000255}.
FT   TRANSMEM    328    348       Helical. {ECO:0000255}.
FT   TOPO_DOM    349    378       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    379    399       Helical. {ECO:0000255}.
FT   TOPO_DOM    400    469       Lumenal. {ECO:0000255}.
FT   TRANSMEM    470    490       Helical. {ECO:0000255}.
FT   TOPO_DOM    491    493       Cytoplasmic. {ECO:0000255}.
FT   VARIANT     256    256       Q -> K (in HPMRS1; dbSNP:rs267606952).
FT                                {ECO:0000269|PubMed:20802478}.
FT                                /FTId=VAR_064190.
FT   VARIANT     341    341       A -> E (in HPMRS1; dbSNP:rs139073416).
FT                                {ECO:0000269|PubMed:20802478}.
FT                                /FTId=VAR_064191.
FT   VARIANT     341    341       A -> V (in HPMRS1; dbSNP:rs139073416).
FT                                {ECO:0000269|PubMed:20802478}.
FT                                /FTId=VAR_064192.
FT   VARIANT     385    385       H -> P (in HPMRS1; dbSNP:rs267606951).
FT                                {ECO:0000269|PubMed:20802478}.
FT                                /FTId=VAR_064193.
FT   MUTAGEN      66     66       W->L: Loss of function.
FT                                {ECO:0000269|PubMed:15623507}.
FT   MUTAGEN      67     67       D->A: Loss of function.
FT                                {ECO:0000269|PubMed:15623507}.
FT   MUTAGEN     293    294       PP->TA: N-glycosylated due to the
FT                                creation of an acceptor site for N-
FT                                glycosylation.
FT                                {ECO:0000269|PubMed:15623507}.
FT   MUTAGEN     308    308       Q->A: Induces a reduces enzyme activity.
FT                                {ECO:0000269|PubMed:15623507}.
FT   MUTAGEN     312    312       W->L: Loss of function.
FT                                {ECO:0000269|PubMed:15623507}.
FT   CONFLICT     33     33       I -> T (in Ref. 1; BAA91196).
FT                                {ECO:0000305}.
SQ   SEQUENCE   493 AA;  55713 MW;  087AE31E51BDD519 CRC64;
     MWPQDPSRKE VLRFAVSCRI LTLMLQALFN AIIPDHHAEA FSPPRLAPSG FVDQLVEGLL
     GGLSHWDAEH FLFIAEHGYL YEHNFAFFPG FPLALLVGTE LLRPLRGLLS LRSCLLISVA
     SLNFLFFMLA AVALHDLGCL VLHCPHQSFY AALLFCLSPA NVFLAAGYSE ALFALLTFSA
     MGQLERGRVW TSVLLFAFAT GVRSNGLVSV GFLMHSQCQG FFSSLTMLNP LRQLFKLMAS
     LFLSVFTLGL PFALFQYYAY TQFCLPGSAR PIPEPLVQLA VDKGYRIAEG NEPPWCFWDV
     PLIYSYIQDV YWNVGFLKYY ELKQVPNFLL AAPVAILVAW ATWTYVTTHP WLCLTLGLQR
     SKNNKTLEKP DLGFLSPQVF VYVVHAAVLL LFGGLCMHVQ VLTRFLGSST PIMYWFPAHL
     LQDQEPLLRS LKTVPWKPLA EDSPPGQKVP RNPIMGLLYH WKTCSPVTRY ILGYFLTYWL
     LGLLLHCNFL PWT
//
